E. Ohman J:or Asset Management’s Esperion Therapeutics ESPR Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,738	Closed	-$632K	–	381
2019 Q1	$632K	Sell	15,738 -14,771	-48%	-$663K	0.04%	214
2018 Q4	$1.4M	Sell	30,509 -45,768	-60%	-$2.21M	0.1%	118
2018 Q3	$3.38M	Buy	76,277 +17,120	+29%	+$786K	0.22%	78
2018 Q2	$2.32M	Buy	+59,157	New	+$2.99M	0.17%	101

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return